Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Cardiovascular and Metabolic Risk

Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population

The Tanno and Sobetsu Study

  1. Hirofumi Ohnishi, MD, PHD,
  2. Shigeyuki Saitoh, MD, PHD,
  3. Satoru Takagi, MD, PHD,
  4. Nobuo Katoh, MD,
  5. Yu Chiba, MD,
  6. Hiroshi Akasaka, MD,
  7. Yosuke Nakamura, MD and
  8. Kazuaki Shimamoto, MD, PHD
  1. Second Department of Internal Medicine, Sapporo Medical University, School of Medicine, Sapporo, Japan
  1. Address correspondence and reprint requests to Hirofumi Ohnishi, MD, PhD, 2nd Department of Internal Medicine, Sapporo Medical University, School of Medicine, S-1, W-16, Chuo-ku, Sapporo 060-8543, Japan. E-mail: hohnishi{at}sapmed.ac.jp
Diabetes Care 2006 May; 29(5): 1128-1129. https://doi.org/10.2337/dc06-0222
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

The Tanno and Sobetsu Study

  • IDF, International Diabetes Federation

According to the new International Diabetes Federation (IDF) definition of metabolic syndrome, for a person to be defined as having metabolic syndrome they must have central obesity defined by waist circumference (1). In the definition, there are some ethnic or country-specific differences in the cutoff points of waist circumference, and Japanese cutoff points have been separately established in the IDF definition (≥85 cm for men and ≥90 cm for women). The Japanese Society of Internal Medicine and eight related scientific societies have also jointly announced new Japanese criteria of metabolic syndrome using the same cutoff points of waist circumference (2). However, the impact of central obesity using the cutoff points as a risk of type 2 diabetes is not known.

In this study, we investigated the incidence of type 2 diabetes in citizens of two rural communities in Japan to determine the relationship between type 2 diabetes and central obesity, and we also investigated the independent effects of central obesity compared with those of overall obesity.

RESEARCH DESIGN AND METHODS

The subjects were 348 men and 523 women selected from 938 citizens who had undergone medical examinations in the towns of Tanno and Sobetsu, Hokkaido, both in 1994 and 2003 or 2004.

The following participants in medical examinations in 1994 were excluded: those with missing data on blood pressure or waist circumference and those with type 2 diabetes (fasting plasma glucose level ≥126 mg/dl and/or those who were on medication for diabetes).

Participants with central obesity were determined according to the new criteria announced by the IDF (1). Central obesity in Japanese is defined by the IDF as waist circumference ≥85 cm for men and ≥90 cm for women. Participants with overall obesity were defined as those with BMI ≥25.0 kg/m2, which is the standard of the Japan Society of the Study of Obesity (3).

The participants were divided into two groups, a normal group and a central obesity group, and the measured items in the two groups were compared. We also compared the incidences of type 2 diabetes in normal and central obesity groups of subjects who were newly determined as having type 2 diabetes on the basis of data obtained from medical examinations conducted in 2003 or 2004. Moreover, we estimated the relative risk of type 2 diabetes in people with central obesity compared with those who did not have central obesity.

As another analysis, the participants were divided into two groups, a normal group and an overall obesity group, and the same assessments as those described above were made for these two groups.

The SPSS package (version 11.5J) was used for statistical analysis. The χ2 test was used for frequency comparison. Multiple logistic regression analysis was used to estimate the relative risk for type 2 diabetes. The significance level of all analyses was set at P < 0.05.

RESULTS

Thirty-eight of the 654 individuals in the normal group and 27 of the 173 individuals in the central obesity group were newly defined as having type 2 diabetes in 2003 or 2004. The incidence of type 2 diabetes was significantly higher in the central obesity group than in the normal group (15.6 vs. 5.8%; P < 0.0001). Thirty-five of the 591 individuals in the normal group and 30 of the 236 individuals in the overall group were newly defined as having type 2 diabetes in 2003 or 2004. The incidence of type 2 diabetes was significantly higher in the overall obesity group than in the normal group (12.7 vs. 5.9%; P < 0.0001).

The results of logistic regression analysis showed that both central obesity and overall obesity were closely related to type 2 diabetes and that the relative risks of occurrence of type 2 diabetes adjusted for age, sex, systolic blood pressure, total cholesterol, and smoking were 2.59 for central obesity and 2.06 for overall obesity (model 2; Table 1). Central obesity maintained its significance when additionally adjusted for overall obesity, but overall obesity lost its significance when additionally adjusted for central obesity (model 3; Table 1).

CONCLUSIONS

Waist circumference is a better predictor of visceral fat (assessed using advanced techniques such as dual-energy X-ray absorptiometry and computed tomography) than BMI and waist-to-hip ratio (4,5,6). There is a strong association between waist circumference and risk of developing health conditions such as cardiovascular disease and type 2 diabetes (7,8,9,10,11). In our study, only central obesity remained a significant predictor of risk of type 2 diabetes when central obesity and overall obesity were included in the model simultaneously.

The IDF also announced a new definition of metabolic syndrome in 2005, and according to the new definition, for a person to be defined as having metabolic syndrome he or she must have central obesity assessed by waist circumference (1). Since there are some ethnic or country-specific differences in cutoff points of waist circumference, ethnic and country-specific cutoff points have been separately established in the IDF definition on the basis of results of various epidemiological studies. Japanese cutoff points have also been independently established in the IDF definition (waist circumference ≥85 cm for men and ≥90 cm for women). The reason for the selection of these cutoff points for Japanese subjects has been described in detail by Matsuzawa et al. (3).

Controversy remains regarding the cutoff points for waist circumference that should be used in clinical practice. The influence of abdominal fatness on health risks such as risk of type 2 diabetes is a continuous one, and any cutoff point is therefore arbitrary (12). Further epidemiological data must be obtained in each country to determine the appropriate country-specific cutoff points for assessing the risk of type 2 diabetes.

In conclusion, our study suggested that the current cutoff points of waist circumference for Japanese people in the IDF definition are useful for assessing the risk of type 2 diabetes and that central obesity may be more useful than overall obesity for evaluating the risk of type 2 diabetes.

View this table:
  • View inline
  • View popup
Table 1—

Comparison of the relative risks for type 2 diabetes in central obesity and overall obesity

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted January 27, 2006.
    • Received January 27, 2006.
  • DIABETES CARE

References

  1. ↵
    International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome [article online]. Available from http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed on 23 January 2006
  2. ↵
    Committee to Evaluate Diagnostic Standards for Metabolic Syndrome: [Definition and the diagnostic standard for metabolic syndrome]. Nippon Naika Gakkai Zasshi 94 : 794 –809,2005 [article in Japanese]
    OpenUrlPubMed
  3. ↵
    Matsuzawa Y, Inoue S, Ikeda Y, Sakata T, Saitoh Y, Satoh Y, Shirai A, Ohno M, Miyazaki S, Tokunaga K, Fukagawa K, Yamanouchi K, Nakamura T: The new diagnostic criteria of obesity (in Japanese). Journal of Japan Society for the Study of Obesity 6 : 18 –28,2000
    OpenUrl
  4. ↵
    Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C: The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord 23 : 801 –809,1999
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A: Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 67 : 44 –49,1998
    OpenUrlAbstract
  6. ↵
    Wang Y, Rimm EB, Stampher MJ, Willet WC, Hu FB: Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81 : 555 –563,2005
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Wei M, Gaskill SP, Haffner SM, Stern MP: Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared with body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study. Obes Res 5 : 16 –23,1997
    OpenUrlPubMedWeb of Science
  8. ↵
    Ledoux M, Lambert J, Reeder BA, Despres JP: Correlation between cardiovascular disease risk factors and simple anthropometric measures: Canadian Heart Health Surveys Research Group. Can Med Assoc J 157(Suppl. 1) : S46 –S53,1997
    OpenUrl
  9. ↵
    Reeder BA, Senthilselvan A, Despres JP, Angel A, Liu L, Wang H, Rabkin SW: The association of cardiovascular disease risk factors with abdominal obesity in Canada: Canadian Heart Health Surveys Research Group. Can Med Assoc J 157(Suppl. 1) : S39 –S45,1997
    OpenUrl
  10. ↵
    Mamtani MR, Kulkarni HR: Predictive performance of anthropometric indexes of central obesity for the risk of type 2 diabetes. Arch Med Res 36 : 581 –589,2005
    OpenUrlCrossRefPubMed
  11. ↵
    Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS, the INTERHEART Study Investigators: Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 366 : 1640 –1649,2005
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Stevens J, Couper D, Pankow J, Folsom AR, Duncan BB, Nieto FJ, Jones D, Tyroler HA: Sensitivity and specificity of anthropometrics for the prediction on diabetes in a biracial cohort. Obes Res 9 : 696 –705,2001
    OpenUrlPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Diabetes Care: 29 (5)

In this Issue

May 2006, 29(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population
Hirofumi Ohnishi, Shigeyuki Saitoh, Satoru Takagi, Nobuo Katoh, Yu Chiba, Hiroshi Akasaka, Yosuke Nakamura, Kazuaki Shimamoto
Diabetes Care May 2006, 29 (5) 1128-1129; DOI: 10.2337/dc06-0222

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population
Hirofumi Ohnishi, Shigeyuki Saitoh, Satoru Takagi, Nobuo Katoh, Yu Chiba, Hiroshi Akasaka, Yosuke Nakamura, Kazuaki Shimamoto
Diabetes Care May 2006, 29 (5) 1128-1129; DOI: 10.2337/dc06-0222
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Differences in Physiological Responses to Cardiopulmonary Exercise Testing in Adults With and Without Type 1 Diabetes: A Pooled Analysis
  • Sedentary Time and Metabolic Risk in Extremely Active Older Adults
  • Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study
Show more Cardiovascular and Metabolic Risk

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.